Both increased TGs and decreased HDL-C levels are the characteristics of dyslipidemia, found in insulin-resistant subjects, while the low HDL-C and high TGs level are the hallmarks of atherogenic dyslipidemia both in diabetic and non-diabetic populations (Group, 1997; Jeppesen et al., 1997; Hermans et al., 2012). This evidence concerns the gene INS and metabolic syndrome.